146 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Sell
Article Searches
Novo Nordisk Is on the Upswing -- for Now https://www.fool.com/investing/2019/02/05/novo-nordisk-is-on-the-upswing-for-now.aspx?source=iedfolrf0000001 Feb 05, 2019 - The full year may be a different story.
Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer http://www.zacks.com/stock/news/352085/mercks-keytruda-clinches-chmp-nod-for-difficult-lung-cancer?cid=CS-ZC-FT-352085 Feb 05, 2019 - Merck (MRK) secures a positive verdict from the Committee for Medicinal Products for Human Use to approve Keytruda's combo therapy for first-line treatment of a difficult lung cancer population.
Sanofi's Myeloma Candidate Meets Goal in Phase III Study http://www.zacks.com/stock/news/352133/sanofis-myeloma-candidate-meets-goal-in-phase-iii-study?cid=CS-ZC-FT-352133 Feb 05, 2019 - Sanofi's (SNY) late-stage candidate, isatuximab, achieves the primary endpoint in a pivotal study by prolonging progression free survival in patients with relapsed/refractory multiple myeloma.
Novo Nordisk (NVO) Q4 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2019/02/02/novo-nordisk-nvo-q4-2018-earnings-conference-call.aspx?source=iedfolrf0000001 Feb 02, 2019 - NVO earnings call for the period ending December 31, 2018.
Novo Nordisk's (NVO) CEO Lars Fruergaard Jørgensen on Q4 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4237599-novo-nordisks-nvo-ceo-lars-fruergaard-jorgensen-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare Feb 01, 2019 - Novo Nordisk A/S (NYSE:NVO) Q4 2018 Earnings Conference Call February 1, 2019 7:00 AM ET Company Participants Lars Fruergaard Jørgensen – Chief Executive Officer Karsten Munk Knudsen – Chief Financial
Novo Nordisk (NVO) Q4 Earnings Miss Estimates, Revenues Beat http://www.zacks.com/stock/news/351653/novo-nordisk-nvo-q4-earnings-miss-estimates-revenues-beat?cid=CS-ZC-FT-351653 Feb 01, 2019 - Novo Nordisk (NVO) fourth-quarter 2018 results mainly benefit from strong performance by Ozempic.
Novo Nordisk Continues Its Balancing Act https://www.fool.com/investing/2018/11/08/novo-nordisk-continues-its-balancing-act.aspx?source=iedfolrf0000001 Nov 08, 2018 - Growth on one hand, but declines on the other.
Novo Nordisk A/S (NVO) CEO Lars Fruergaard Jørgensen on Q3 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4217252-novo-nordisk-s-nvo-ceo-lars-fruergaard-jorgensen-q3-2018-results-earnings-call-transcript?source=feed_sector_healthcare Nov 01, 2018 -
Novo Nordisk (NVO) Q3 2018 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/11/01/novo-nordisk-as-nvo-q3-2018-earnings-conference-ca.aspx?source=iedfolrf0000001 Nov 01, 2018 - NVO earnings call for the period ending September 30, 2018.
PFE or NVO: Which Is the Better Value Stock Right Now? http://www.zacks.com/stock/news/327938/pfe-or-nvo-which-is-the-better-value-stock-right-now?cid=CS-ZC--327938 Oct 15, 2018 - PFE vs. NVO: Which Stock Is the Better Value Option?

Pages: 1234567...15

<Page 2>